1. Home
  2. PDS vs CRGX Comparison

PDS vs CRGX Comparison

Compare PDS & CRGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PDS
  • CRGX
  • Stock Information
  • Founded
  • PDS 1951
  • CRGX 2021
  • Country
  • PDS Canada
  • CRGX United States
  • Employees
  • PDS N/A
  • CRGX N/A
  • Industry
  • PDS
  • CRGX
  • Sector
  • PDS
  • CRGX
  • Exchange
  • PDS Nasdaq
  • CRGX Nasdaq
  • Market Cap
  • PDS 649.5M
  • CRGX 190.0M
  • IPO Year
  • PDS N/A
  • CRGX 2023
  • Fundamental
  • Price
  • PDS $50.78
  • CRGX $4.46
  • Analyst Decision
  • PDS Buy
  • CRGX Hold
  • Analyst Count
  • PDS 1
  • CRGX 7
  • Target Price
  • PDS $95.00
  • CRGX $4.67
  • AVG Volume (30 Days)
  • PDS 120.2K
  • CRGX 502.9K
  • Earning Date
  • PDS 07-29-2025
  • CRGX 08-11-2025
  • Dividend Yield
  • PDS N/A
  • CRGX N/A
  • EPS Growth
  • PDS N/A
  • CRGX N/A
  • EPS
  • PDS 5.20
  • CRGX N/A
  • Revenue
  • PDS $1,301,611,298.00
  • CRGX N/A
  • Revenue This Year
  • PDS $1.35
  • CRGX $57.81
  • Revenue Next Year
  • PDS $0.99
  • CRGX N/A
  • P/E Ratio
  • PDS $9.00
  • CRGX N/A
  • Revenue Growth
  • PDS N/A
  • CRGX N/A
  • 52 Week Low
  • PDS $36.20
  • CRGX $3.00
  • 52 Week High
  • PDS $79.07
  • CRGX $25.45
  • Technical
  • Relative Strength Index (RSI)
  • PDS 62.11
  • CRGX 57.89
  • Support Level
  • PDS $46.44
  • CRGX $4.09
  • Resistance Level
  • PDS $47.83
  • CRGX $4.51
  • Average True Range (ATR)
  • PDS 1.59
  • CRGX 0.18
  • MACD
  • PDS -0.07
  • CRGX 0.00
  • Stochastic Oscillator
  • PDS 74.75
  • CRGX 77.18

About PDS Precision Drilling Corporation

Precision Drilling Corp is a provider of contract drilling and completion and production services to oil and natural gas exploration and production companies in Canada, the United States, and certain international locations. Contract Drilling Services include drilling rigs, procurement and distribution of oilfield supplies, and the manufacture, sale and repair of drilling equipment. Completion and Production Services include service rigs, oilfield equipment rental, and camp and catering services.

About CRGX CARGO Therapeutics Inc.

Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platforms, and manufacturing are designed to directly address the limitations of approved chimeric antigen receptor (CAR) T-cell therapies. Its product includes CRG-023, an investigational tri-specific CAR T designed to address several known causes of relapse associated with existing CAR T-cell therapies such as loss of tumor antigen expression, loss of co-stimulation (e.g., via CD58/CD2 signaling) and T cell exhaustion. CRG-023 is designed to target the B-cell lineage antigens (CD19, CD20, CD22) via tri-cistronic expression of three distinct CARs from a single lentiviral vector.

Share on Social Networks: